Flaherty, K. R., Brown, K. K., Wells, A. U., Clerisme-Beaty, E., Collard, H. R., Cottin, V., . . . Schlenker-Herceg, R. (2017). Design of the PF-ILD trial: A double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. BMJ Open Respir Res.
Chicago-стиль цитированияFlaherty, Kevin R., et al. "Design of the PF-ILD Trial: A Double-blind, Randomised, Placebo-controlled Phase III Trial of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease." BMJ Open Respir Res 2017.
MLA-цитированиеFlaherty, Kevin R., et al. "Design of the PF-ILD Trial: A Double-blind, Randomised, Placebo-controlled Phase III Trial of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease." BMJ Open Respir Res 2017.